Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Positive”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Looking for participantsNCT07020533
What this trial is testing

A Vaccine (CMV-MVA Triplex Vaccine) for the Enhancement of CMV-Specific Immunity and the Prevention of CMV Viremia in Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplant

Who this might be right for
Accelerated Phase Chronic Myeloid Leukemia, BCR-ABL1 PositiveAcute Lymphoblastic LeukemiaAcute Myeloid Leukemia+9 more
City of Hope Medical Center 46
Not applicableNot Yet RecruitingNCT07246538
What this trial is testing

Positive Airway Pressure (PAP) System Evaluation in Volunteers

Who this might be right for
Obstruction Airway
University of Utah 25
Testing effectiveness (Phase 2)Ended earlyNCT00570258
What this trial is testing

Randomized, Double Blind Multicenter Phase II Study of Time to Progression on Fulvestrant in Combination With Erlotinib or Placebo in Hormone Receptor-Positive Metastatic Breast Cancer (MBC) Subjects Who Progressed on First Line Hormonal Therapy

Who this might be right for
Metastatic Breast Cancer
University of Arkansas 27
Early research (Phase 1)Active Not RecruitingNCT03401385
What this trial is testing

First-in-human Study of DS-1062a for Advanced Solid Tumors (TROPION-PanTumor01)

Who this might be right for
Hormone Receptor Positive Breast CancerTriple Negative Breast CancerNon-small Cell Lung Cancer
Daiichi Sankyo Co., Ltd. 890
Not applicableLooking for participantsNCT06104085
What this trial is testing

99mTc-MY6349 SPECT/CT Imaging in Trop2-positive Triple-negative Breast Cancer

Who this might be right for
Breast Cancer
Peking Union Medical College Hospital 30
Testing effectiveness (Phase 2)Study completedNCT00170443
What this trial is testing

Trivalent rHA Dose Escalation Study in Elderly Subjects

Who this might be right for
Influenza
National Institute of Allergy and Infectious Diseases (NIAID) 399
Not applicableStudy completedNCT01099735
What this trial is testing

Effect of Continuous Positive Airway Pressure (CPAP) on Lower Esophageal Sphincter Pressure in Morbidly Obese Patients

Who this might be right for
Sleep ApneaGastroesophageal Reflux Disease
Oregon Health and Science University 20
Not applicableStudy completedNCT03072576
What this trial is testing

Accuracy and Feasibility of Xpert Ultra

Who this might be right for
Tuberculosis, Pulmonary
Foundation for Innovative New Diagnostics, Switzerland 1,400
Not applicableUnknownNCT05031091
What this trial is testing

Epidemiology of Leprosy in French Guiana

Who this might be right for
Hansen's Disease
Centre Hospitalier de Cayenne 368
Large-scale testing (Phase 3)Looking for participantsNCT05549297
What this trial is testing

Tebentafusp Regimen Versus Investigator's Choice in Previously Treated Advanced Melanoma (TEBE-AM)

Who this might be right for
Advanced Melanoma
Immunocore Ltd 540
Early research (Phase 1)Study completedNCT00111397
What this trial is testing

Adjuvant Cytokine Therapy to Treat Pulmonary Mycobacterium Avium Complex Infection

Who this might be right for
Mycobacterium Avium-Intracellulare Infection
National Institute of Allergy and Infectious Diseases (NIAID) 2
Testing effectiveness (Phase 2)Ended earlyNCT04059484
What this trial is testing

Phase 2 Study of Amcenestrant (SAR439859) Versus Physician's Choice in Locally Advanced or Metastatic ER-positive Breast Cancer

Who this might be right for
Breast Cancer Metastatic
Sanofi 367
Testing effectiveness (Phase 2)Study completedNCT02210858
What this trial is testing

Tipifarnib in Treating Patients With Chronic Myeloid Leukemia, Chronic Myelomonocytic Leukemia, or Undifferentiated Myeloproliferative Disorders

Who this might be right for
Accelerated Phase of DiseaseAtypical Chronic Myeloid Leukemia, BCR-ABL1 NegativeChronic Myelogenous Leukemia, BCR-ABL1 Positive+4 more
National Cancer Institute (NCI) 31
Early research (Phase 1)Looking for participantsNCT06128148
What this trial is testing

Phase I Study of JYP0322 in ROS1 Fusion-Positive Solid Tumors

Who this might be right for
Protein Kinase InhibitorsOther Protocol Specified CriteriaLung Neoplasms+1 more
Guangzhou JOYO Pharma Co., Ltd 101
Not applicableEnded earlyNCT03848585
What this trial is testing

Medicine Adherence and Effects on Transplants With Pilloxa's Electronic Pillbox

Who this might be right for
Kidney Transplant; ComplicationsLiver Transplant; Complications
Pilloxa 25
Testing effectiveness (Phase 2)Looking for participantsNCT04150640
What this trial is testing

Oxaliplatin and Liposomal Irinotecan (Plus Trastuzumab for HER2-positive Disease) in Advanced Esophageal and Gastric Adenocarcinoma

Who this might be right for
Esophageal AdenocarcinomaGastric Adenocarcinoma
University of Wisconsin, Madison 52
Not applicableActive Not RecruitingNCT04567368
What this trial is testing

TB-CAPT MTB/XDR Study

Who this might be right for
TuberculosisResistance BacterialDiagnoses Disease
Foundation for Innovative New Diagnostics, Switzerland 753
Not applicableStudy completedNCT04076189
What this trial is testing

Time of Positive Pressure Ventilation in Non-vigorous Infants Born Through Meconium-stained Amniotic Fluid

Who this might be right for
Meconium Aspiration SyndromeInfant, Newborn, DiseaseNeonatal Resuscitation
University Hospital Padova 40
Testing effectiveness (Phase 2)Looking for participantsNCT07486089
What this trial is testing

Dual-Target CAR-NK Cells for Advanced Breast Cancer (HER2+ and TNBC)

Who this might be right for
Breast Cancer (Locally Advanced or Metastatic)HER2-positive Breast CancerTriple-Negative Breast Cancer (TNBC)
Beijing Biotech 60
Testing effectiveness (Phase 2)Study completedNCT00391989
What this trial is testing

Treatment of Adult Ph+ LAL With BMS-354825

Who this might be right for
Lymphoblastic Leukemia, Acute
Gruppo Italiano Malattie EMatologiche dell'Adulto 53
Next Page